查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030年全球自动输液系统市场
市场调查报告书
商品编码
1296897

2023-2030年全球自动输液系统市场

Global Autotransfusion Systems Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

由于人们对血液短缺和输血安全越来越关注，自体输血的意义越来越大。随着血液保存方法、输血医学、血液成分分离技术的进步，以及临床需求的不断增长，ABT技术的范围得到了很大程度的扩大和创新。在器官移植手术中，对失血的管理有很大的需求。因此，自体输血被作为一种策略来利用，以减少异体输血的有害影响的发生。采用这种方法是为了避免极端使用捐赠的血液。

术前自体输血包括收集病人的血液并储存一段时间。由于肝脏移植没有确定的日期，不包括涉及活体捐赠者的病例，提前采血通常是不可行的。因此，术中抢救性自体输血（IBSA）被作为自体输血的一种策略。IBSA包括在手术过程中回收损失的血液，并通过输血将其送回病人体内。这消除了对异体输血的需要，因为异体输血可能会对受血者的生存产生影响，并产生免疫抑制作用。异体输血增加了病毒感染的传播和病人之间输血错误的风险。这反过来又促进了器官移植手术中对自动输血系统的需求，以管理失血，提高手术中的安全性和有效性。

目录

第一章：报告摘要

  • 当前行业分析和增长潜力展望
  • 研究方法和工具
  • 市场细分
    • 按领域划分
    • 按地区

第二章：市场概述和洞察力

  • 报告的范围
  • 分析师的洞察力和当前的市场趋势
    • 主要发现
    • 建议
    • 总结

第三章：竞争格局

  • 主要公司分析
  • Medtronic plc
    • 概述
    • 财务分析
    • SWOT分析
    • 近期发展情况
  • Fresenius KabiAG
    • 概况
    • 财务分析
    • SWOT分析
    • 近期发展情况
  • Becton, Dickinson& Co.
    • 进展概况
    • 财务分析
    • SWOT分析
    • 近期发展情况
  • LivaNova PLC
    • 进展概况
    • 财务分析
    • SWOT分析
    • 近期发展情况
  • B. Braun Melsungen AG
    • 进展概况
    • 财务分析
    • SWOT分析
    • 近期发展
  • 关键战略分析

第四章：市场细分

  • 全球自动输血系统的应用市场
    • 骨科手术
    • 心脏手术
    • 创伤手术
    • 器官移植
    • 其他手术
  • 按类型分類的全球自动输血系统市场
    • 自体输血产品
    • 辅料

第五章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 意大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第六章：公司简介

  • Advancis Surgical
  • Atrium Medical Corp.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Co.
  • Beijing ZKSK Technology Co., Ltd.
  • BraileBiomedica
  • Brightwake Ltd.
  • Ecomed Solutions, LLC
  • Fresenius KabiAG
  • Gen World Medical Devices
  • Getinge AB
  • Haemonetics Corp.
  • LivaNova PLC
  • Medtronic plc
  • Palex Medical SA
  • RedaxS.p.a.
  • Sarstedt Ag & Co. KG
  • Stryker Corp.
  • Teleflex Inc.
  • Terumo Corp.
  • Zimmer Biomet Holdings, Inc.
Product Code: OMR2027369

Global autotransfusion systems market is estimated to grow at a CAGR of 5.6% during the forecast period. The major factors contributing to the market growth include the rising number of surgeries, increasing demand for organ transplantation, and emerging focus on patient blood management. The rising number of organ transplantation procedures have witnessed over the years. For instance, as per the Global Observatory on Donation and Transplantation (GODT), in 2017, the number of organs transplanted was 139,024, which increased to 7.3% over 2015. There were 16 transplants per hour in 2017. Of these, 90,306 kidney transplants and 32,348 liver transplants were performed in 2017. This rising demand for organ transplants is leading to increasing demand for autologous blood transfusion for patients' blood management during the organ transplantation procedure.

Autologous blood transfusion has been increasingly gaining significance owing to the growing concerns about blood shortage and blood transfusion safety. With the advances in blood conservation methods, blood transfusion medicine, blood component separation technology, and continuous growth in clinical needs, the scope of ABT technology has been broadened and innovated to a significant extent. There is a significant need for the management of blood loss in organ transplantation procedures. As a result, autologous transfusion is utilized as a strategy to minimize the incidence of the harmful effects of allogeneic transfusion. The method is employed to avoid the extreme use of donated blood.

Preoperative autologous transfusion involves collecting patients' blood and stored for some time. As there is no determined date for liver transplants, excluding cases that involve living donors, blood collection in advance is normally not feasible. Therefore, intraoperative blood salvage autotransfusion (IBSA) is employed as a strategy for autologous transfusion. IBSA involves the recovery of blood loss during the procedure and returns it to the patient's body by infusion. This eliminates the need for an allogeneic blood transfusion which may have an impact on recipient survival and an immunosuppressive effect. Allogeneic transfusion increases the risk of transmission of viral infections and transfusion errors among patients. This, in turn, is contributing to the demand for autotransfusion systems in organ transplant procedures to manage blood loss and increase safety and effectiveness during the procedure.

Segmental Outlook

The global autotransfusion systems market is segmented based on application and type. Based on application, the market is classified into orthopedic surgery, cardiac surgery, trauma procedures, organ transplantation, and other procedures. Based on type, the market is classified into autotransfusion products and accessories.

Cardiac surgeries held a significant share of the application segment

The rising number of cardiac surgeries coupled with significant blood loss during the procedure is primarily strengthening the demand for autotransfusion systems in cardiac surgeries. Autologous transfusion is an easy valuable concept to save blood and minimize the transfusion requirement in the postoperative period in cardiopulmonary bypass and open-heart surgeries. It minimizes the requirement for allogeneic blood products in adult cardiac surgery. Preoperative autologous is a safe and efficient option for allogeneic transfusion. Patients suffering from rare blood phenotypes or allogeneic antibodies is expected to benefit from autologous transfusion as compatible allogeneic blood may not be always available.

Allogeneic transfusion is associated with potential complications that can be removed or reduced while autologous blood is administered. These complications include alloimmunization, transfusion-transmitted infectious diseases, hemolytic reactions, and allergic and febrile reactions. The withdrawal of autologous blood earlier conducting cardiopulmonary bypass preserves red cell mass protects the platelets, and decreases allogeneic transfusion needs. The appropriate condition for autologous blood donation is elective cardiac surgery where there is a high probability of blood transfusion.

Regional Outlook

The global autotransfusion systems market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. North America has witnessed potential in the market owing to the increasing prevalence of chronic diseases, including CVD and cancer, and significant blood management programs in the programs. Several universities and hospitals have focused on blood management programs to maintain safety and efficiency in the procedure. For instance, in 2010, Mayo Clinic implemented a patient blood-management program and has since experienced a 35%decrease in blood transfusions, increasing patient outcomes and achieving considerable savings. This, in turn, is contributing to the demand for autotransfusion systems to reduce the need for donated blood and eliminates the detrimental effects of allogeneic transfusion.

Asia-Pacific is expected to witness significant growth during the forecast period

Asia-Pacific is estimated to show significant growth during the forecast period owing to the increasing number of multi-specialty hospitals and rising incidences of orthopedic and CVD in the region. In addition, growing medical tourism is expected to offer an opportunity for market growth in the region. India Brand Equity Foundation (IBEF) estimated that the medical tourism market in India was valued at $3 billion in 2017. During the period, 2018-2019, the Indian medical tourism market is expected to double owing to the easier norms for medical visa approvals. The number of Foreign Tourist Arrivals (FTAs) in India on medical visas increased by 15.9% year-on-year to an estimated 495,056 in 2017 from 427,014 in 2016.

In India, the Joint Commission International (JCI) - accredited hospitals are 21 and are growing significantly. The presence of skilled pediatric experts in India is further attributed to the positive demand for the congenital heart disease market. As per Indian Pediatrics, currently, India has approximately 130 pediatric cardiologists and 110 pediatric cardiac surgeons. As a large number of infants are born with congenital heart defects globally, the availability of skilled cardiac surgeons and cost-effective and reliable treatment is estimated to contribute to the growth of medical tourism in the country. This, in turn, is encouraging hospitals to focus on patient safety and thereby contributing to the demand for autotransfusion systems to manage patients' blood.

Market Players Outlook

The major players in the market include Medtronic plc, Fresenius Kabi AG, Becton, Dickinson & Co., LivaNova PLC, and B. Braun Melsungen AG. The market players are adopting strategies such as mergers and acquisitions and product launches, to expand market share and gain a competitive advantage over their competitors. For instance, in April 2019, Ecomed Solutions launched HEMAsavR, a device for blood capture and transfer that will support medical professionals decrease complex and costly allogeneic blood transfusions. It is universally compatible with surgical suction and autologous transfusion systems, which makes it easy to integrate into current protocols. It is primarily beneficial to hospitals that perform orthopedic, cardiac, vascular, trauma, organ transplant, obstetrics/gynecology, thoracic, neurosurgery, general, and urology procedures.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Medtronic plc
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Fresenius KabiAG
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Becton, Dickinson& Co.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. LivaNova PLC
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. B. Braun Melsungen AG
    • 3.6.1. Overview
    • 3.6.2. Financial Analysis
    • 3.6.3. SWOT Analysis
    • 3.6.4. Recent Developments
  • 3.7. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Autotransfusion Systems Market by Application
    • 4.1.1. Orthopedic Surgery
    • 4.1.2. Cardiac Surgery
    • 4.1.3. Trauma Procedures
    • 4.1.4. Organ Transplantation
    • 4.1.5. Other Procedures
  • 4.2. Global Autotransfusion Systems Market by Type
    • 4.2.1. Autotransfusion Products
    • 4.2.2. Accessories

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Advancis Surgical
  • 6.2. Atrium Medical Corp.
  • 6.3. B. Braun Melsungen AG
  • 6.4. Becton, Dickinson and Co.
  • 6.5. Beijing ZKSK Technology Co., Ltd.
  • 6.6. BraileBiomedica
  • 6.7. Brightwake Ltd.
  • 6.8. Ecomed Solutions, LLC
  • 6.9. Fresenius KabiAG
  • 6.10. Gen World Medical Devices
  • 6.11. Getinge AB
  • 6.12. Haemonetics Corp.
  • 6.13. LivaNova PLC
  • 6.14. Medtronic plc
  • 6.15. Palex Medical SA
  • 6.16. RedaxS.p.a.
  • 6.17. Sarstedt Ag & Co. KG
  • 6.18. Stryker Corp.
  • 6.19. Teleflex Inc.
  • 6.20. Terumo Corp.
  • 6.21. Zimmer Biomet Holdings, Inc.

LIST OF TABLES

  • 1. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 2. GLOBAL AUTOTRANSFUSION SYSTEMS IN ORTHOPEDIC SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL AUTOTRANSFUSION SYSTEMS IN CARDIAC SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL AUTOTRANSFUSION SYSTEMS IN TRAUMA PROCEDURES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL AUTOTRANSFUSION SYSTEMS IN ORGAN TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL AUTOTRANSFUSION SYSTEMS IN OTHER PROCEDURES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 8. GLOBAL AUTOTRANSFUSION PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL AUTOTRANSFUSION ACCESSORIES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2022-2030 ($ MILLION)
  • 10. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 14. EUROPEAN AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. EUROPEAN AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 16. EUROPEAN AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 17. ASIA-PACIFIC AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. ASIA-PACIFIC AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 19. ASIA-PACIFIC AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD AUTOTRANSFUSION SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 2. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 3. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL AUTOTRANSFUSION SYSTEMS IN ORTHOPEDIC SURGERY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL AUTOTRANSFUSION SYSTEMS IN CARDIAC SURGERY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL AUTOTRANSFUSION SYSTEMS IN TRAUMA PROCEDURES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL AUTOTRANSFUSION SYSTEMS IN ORGAN TRANSPLANTATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL AUTOTRANSFUSION SYSTEMS IN OTHER PROCEDURES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL AUTOTRANSFUSION PRODUCTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL AUTOTRANSFUSION ACCESSORIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. US AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. CANADA AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. UK AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. FRANCE AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. GERMANY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. ITALY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. SPAIN AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. ROE AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. INDIA AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. CHINA AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. JAPAN AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF ASIA-PACIFIC AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF THE WORLD AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)